Altria Group, Inc. logo

Altria Group, Inc. (MO)

Market Closed
23 Feb, 20:00
NYSE NYSE
$
68. 98
+1.41
+2.09%
$
113.43B Market Cap
8.52 P/E Ratio
4.24% Div Yield
7,147,623 Volume
4.95 Eps
$ 67.57
Previous Close
Day Range
67.4 69.1
Year Range
52.82 69.1
Want to track MO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MO earnings report is expected in 62 days (27 Apr 2026)
Compared to Estimates, Altria (MO) Q4 Earnings: A Look at Key Metrics

Compared to Estimates, Altria (MO) Q4 Earnings: A Look at Key Metrics

While the top- and bottom-line numbers for Altria (MO) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 3 weeks ago
Altria (MO) Lags Q4 Earnings Estimates

Altria (MO) Lags Q4 Earnings Estimates

Altria (MO) came out with quarterly earnings of $1.3 per share, missing the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.29 per share a year ago.

Zacks | 3 weeks ago
Altria Profit Falls as Cigarette Sales Decline

Altria Profit Falls as Cigarette Sales Decline

Altria reported lower fourth-quarter profit as cigarette shipment volume declined, dragging down its smokeable product business.

Wsj | 3 weeks ago
Altria's Q4 Earnings on the Deck: How to Play the Stock

Altria's Q4 Earnings on the Deck: How to Play the Stock

MO's fourth-quarter results are likely to reflect pricing strength and cost discipline, offsetting ongoing cigarette volume pressure.

Zacks | 3 weeks ago
Altria Expands Beyond Nicotine: Is MO's Strategy Worth Watching?

Altria Expands Beyond Nicotine: Is MO's Strategy Worth Watching?

MO is evaluating non-nicotine and wellness categories through a KT&G collaboration as part of a long-term effort to diversify beyond tobacco.

Zacks | 3 weeks ago
Insights Into Altria (MO) Q4: Wall Street Projections for Key Metrics

Insights Into Altria (MO) Q4: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of Altria (MO) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 4 weeks ago
Altria (MO) Surpasses Market Returns: Some Facts Worth Knowing

Altria (MO) Surpasses Market Returns: Some Facts Worth Knowing

In the closing of the recent trading day, Altria (MO) stood at $61.91, denoting a +1.44% move from the preceding trading day.

Zacks | 1 month ago
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth

Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth

Altria (MO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 month ago
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It

Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It

Altria (MO) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 1 month ago
Will Altria (MO) Beat Estimates Again in Its Next Earnings Report?

Will Altria (MO) Beat Estimates Again in Its Next Earnings Report?

Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks | 1 month ago
MO Stock At $62: Time To Take Profits Or Ride The Momentum?

MO Stock At $62: Time To Take Profits Or Ride The Momentum?

Altria stock has risen 8% this year due to analyst optimism regarding its smoke-free products. However, does the surge make it too costly?

Forbes | 1 month ago
Altria's Smoke-Free Push: Is It Finally Gaining Real Momentum?

Altria's Smoke-Free Push: Is It Finally Gaining Real Momentum?

MO is making steady progress in the smoke-free transition, with oral nicotine gaining traction as it reshapes the business focus.

Zacks | 1 month ago
Loading...
Load More